Novo Nordisk   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1989)

Organization Overview

First Clinical Trial
1989
NCT01518036
First Marketed Drug
1989
Insulin, porcine
First NDA Approval
2005
insulin detemir (Levemir)
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Novo Nordic | NOVO NORDISK | Novo Nordisk A/S | NOVO NORDISK INC | Novo Nordisk India Ltd | Novo Nordisk India Private Ltd. | Novo Nordisk Pharma Ltd | Novo Nordisk Pharma Ltd. | The Novo Nordic Foundation | The Novo Nordisk Foundation | The Novo Nordisk Foundation Center for Basic Metabolic Research | The Novo Nordisk UK Research Foundation